[Value of clindamycin in the treatment of ocular toxoplasmosis]. (Record no. 9274617)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01429 a2200445 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250513124940.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 199710s 0 0 fre d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0181-5512 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Jeddi, A |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 19971009 |
245 00 - TITLE STATEMENT | |
Title | [Value of clindamycin in the treatment of ocular toxoplasmosis]. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Journal francais d'ophtalmologie |
Date of publication, distribution, etc. | 1997 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 418-22 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial; Comparative Study; English Abstract; Journal Article; Randomized Controlled Trial |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adolescent |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anti-Bacterial Agents |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anti-Infective Agents |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Child |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Chorioretinitis |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Clindamycin |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Therapy, Combination |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prospective Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyrimethamine |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Recurrence |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sulfadiazine |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Toxoplasmosis, Ocular |
General subdivision | complications |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Azaiez, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bouguila, H |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kaoueche, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Malouche, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Daghfous, F |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ayed, S |
773 0# - HOST ITEM ENTRY | |
Title | Journal francais d'ophtalmologie |
Related parts | vol. 20 |
-- | no. 6 |
-- | p. 418-22 |
No items available.